Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation

BackgroundBecause the κ-opioid receptor (OR) agonist U50488H stimulates opioidergic regulation and inhibits L-type Ca2+ channels, this study was aimed at assessing the roles of OR and L-type Ca2+ channels on U50488H-induced cardioprotection.MethodsLangendorff-perfused rat hearts were subjected to 30...

Full description

Bibliographic Details
Main Authors: Kook Jin Chun, Young Ho Jang, June Hong Kim, Jun Kim, Yong Hyun Park
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2010-02-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kjae-58-162.pdf
id doaj-4614effb928f490a8b21fc0992973805
record_format Article
spelling doaj-4614effb928f490a8b21fc09929738052020-11-25T03:43:53ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632010-02-0158216216810.4097/kjae.2010.58.2.1626843Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulationKook Jin Chun0Young Ho Jang1June Hong Kim2Jun Kim3Yong Hyun Park4Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.Institute of Cardiovascular Research Center, Pusan National University Yangsan Hospital, Yangsan, Korea.BackgroundBecause the κ-opioid receptor (OR) agonist U50488H stimulates opioidergic regulation and inhibits L-type Ca2+ channels, this study was aimed at assessing the roles of OR and L-type Ca2+ channels on U50488H-induced cardioprotection.MethodsLangendorff-perfused rat hearts were subjected to 30 min of regional ischemia and 2 h of reperfusion. Isolated hearts were treated with U50488H with or without the κ-OR antagonist nor-binaltorphimine (nor-BNI) or the Ca2+ channels activator BAY K 8644. Infarct size was measured with 2,3,5-triphenyltetrazolium chloride staining.ResultsU50488H treatment at reperfusion: (1) significantly reduced infarct size (11.3 ± 1.3%) compared to control hearts (27.7 ± 1.1%, P < 0.001), an effect that was completely blocked by nor-BNI (24.0 ± 0.9%, P < 0.001 vs. U50488H) but not by BAY K 8644 (7.1 ± 1.7%, P > 0.05 vs. U50488H); (2) significantly increased left ventricular developed pressure (65.3 ± 4.8%) after 2 h of reperfusion compared to control hearts (44.8 ± 3.6%, P < 0.05), an effect that was abrogated by nor-BNI (40.5 ± 4.5%, P > 0.05 vs. control) but not by BAY K 8644 (64.3 ± 5.6%, P < 0.01 vs. control); and (3) significantly decreased heart rate (P < 0.01 vs. control), an effect that was completely abrogated by both nor-BNI and BAY K 8644.ConclusionsU50488H significantly limits myocardial infarction and stunning in isolated rat hearts after ischemia-reperfusion induction. The infarct size limitation and contractility improvement observed with U50488H treatment during reperfusion are entirely mediated by OR stimulation and not by Ca2+ channel modulation.http://ekja.org/upload/pdf/kjae-58-162.pdfcoronary occlusionmyocardial infarctionopioid receptorsreperfusion
collection DOAJ
language English
format Article
sources DOAJ
author Kook Jin Chun
Young Ho Jang
June Hong Kim
Jun Kim
Yong Hyun Park
spellingShingle Kook Jin Chun
Young Ho Jang
June Hong Kim
Jun Kim
Yong Hyun Park
Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
Korean Journal of Anesthesiology
coronary occlusion
myocardial infarction
opioid receptors
reperfusion
author_facet Kook Jin Chun
Young Ho Jang
June Hong Kim
Jun Kim
Yong Hyun Park
author_sort Kook Jin Chun
title Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
title_short Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
title_full Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
title_fullStr Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
title_full_unstemmed Cardioprotection by kappa-opioid receptor agonist U50488H is mediated by opioidergic regulation but not by calcium current modulation
title_sort cardioprotection by kappa-opioid receptor agonist u50488h is mediated by opioidergic regulation but not by calcium current modulation
publisher Korean Society of Anesthesiologists
series Korean Journal of Anesthesiology
issn 2005-6419
2005-7563
publishDate 2010-02-01
description BackgroundBecause the κ-opioid receptor (OR) agonist U50488H stimulates opioidergic regulation and inhibits L-type Ca2+ channels, this study was aimed at assessing the roles of OR and L-type Ca2+ channels on U50488H-induced cardioprotection.MethodsLangendorff-perfused rat hearts were subjected to 30 min of regional ischemia and 2 h of reperfusion. Isolated hearts were treated with U50488H with or without the κ-OR antagonist nor-binaltorphimine (nor-BNI) or the Ca2+ channels activator BAY K 8644. Infarct size was measured with 2,3,5-triphenyltetrazolium chloride staining.ResultsU50488H treatment at reperfusion: (1) significantly reduced infarct size (11.3 ± 1.3%) compared to control hearts (27.7 ± 1.1%, P < 0.001), an effect that was completely blocked by nor-BNI (24.0 ± 0.9%, P < 0.001 vs. U50488H) but not by BAY K 8644 (7.1 ± 1.7%, P > 0.05 vs. U50488H); (2) significantly increased left ventricular developed pressure (65.3 ± 4.8%) after 2 h of reperfusion compared to control hearts (44.8 ± 3.6%, P < 0.05), an effect that was abrogated by nor-BNI (40.5 ± 4.5%, P > 0.05 vs. control) but not by BAY K 8644 (64.3 ± 5.6%, P < 0.01 vs. control); and (3) significantly decreased heart rate (P < 0.01 vs. control), an effect that was completely abrogated by both nor-BNI and BAY K 8644.ConclusionsU50488H significantly limits myocardial infarction and stunning in isolated rat hearts after ischemia-reperfusion induction. The infarct size limitation and contractility improvement observed with U50488H treatment during reperfusion are entirely mediated by OR stimulation and not by Ca2+ channel modulation.
topic coronary occlusion
myocardial infarction
opioid receptors
reperfusion
url http://ekja.org/upload/pdf/kjae-58-162.pdf
work_keys_str_mv AT kookjinchun cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation
AT younghojang cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation
AT junehongkim cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation
AT junkim cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation
AT yonghyunpark cardioprotectionbykappaopioidreceptoragonistu50488hismediatedbyopioidergicregulationbutnotbycalciumcurrentmodulation
_version_ 1724517805784563712